LATEST NEWS:

ALERTNET INSIGHT

Exclusive, in-depth reporting from our correspondents

TOOLS

AlertNet for journalistsTools and training for the media

Job vacanciesCareers in aid and relief

Interactive statisticsExplore humanitarian facts and figures

DO MORE with AlertNet

  • Subscribe
  • RSS feeds
  • Facebook
  • Twitter
  • LinkedIn
  • Posterous
  • YouTube

Health and Science - Fighting back against pneumonia

By Bill Roedy | Mon., November 14, 10:13 AM | Comments ( 2 )

A child suffering from pneumonia lies in a Muzaffarabad hospital in Pakistan in this file picture. REUTERS/Goran Tomasevic

A child suffering from pneumonia lies in a Muzaffarabad hospital in Pakistan in this file picture. REUTERS/Goran Tomasevic

Bill Roedy is former CEO of MTV and GAVI special envoy. The opinions expressed are his own.

As a music lover and former CEO of MTV Networks International, I’ve spent decades trying to give voice to young people struggling for creative freedom.

More recently though I’ve also taken to a new cause: the struggle of babies and children in poor countries just to survive.

Few people can even name the leading global killer of young children - it’s pneumonia - and it claims a child’s life every 20 seconds.

Not surprisingly, the overwhelming majority of these deaths take place in the developing world where access to health prevention and care is sometimes complicated.

World Pneumonia Day, November 12, provided an opportunity to remember those many young lives lost to pneumonia which could have been prevented in large part with vaccines, access to simple antibiotics and improved nutrition.

If we could ensure that existing vaccines reach those children who need them most we would make a huge difference in preventing the more than 1.5 million young lives lost each year to this devastating disease.

Until recently, it would have taken 10 to 15 years for a vaccine released in the United States or Europe to be available in the developing world.

Thankfully, the GAVI Alliance, which works towards saving children's lives by increasing access to immunisation in poor countries, has been able to dramatically accelerate that timeline for the introduction of the pneumococcal vaccines, bringing them to the developing world much faster.  GAVI is an innovative and effective organisation which aims to use the same model for other lifesaving vaccines.


On World Pneumonia Day, Malawi became the 16th GAVI-supported country to introduce this life-saving vaccine.

Three million children living in developing countries have already been reached, and another ten million are expected to receive the vaccine in 2012.

This fact is especially important when one considers that 98.5 percent of pneumonia deaths occur in less developed countries, where distance, poverty and other factors put medical care out of reach for many.

As parents, we would stop at nothing to protect our children if they were sick.  Many families – in rich and poor countries alike – are living in poverty or debt as a result of sickness in the family.

By preventing disease in the first place, immunisation can eliminate the need for hospitalisation or expensive medical treatment, and in many cases help families avoid succumbing to poverty.

The introduction of the pneumococcal vaccine into the world’s poorest countries is a cornerstone of GAVI’s ambitious plan to ensure that all of the world’s children have a healthy start in life. But much remains to be done.

Millions of children still do not receive this vaccine as well as other routine immunisations, and GAVI will need the continuing support and commitment of its donors to ensure that they do.


By 2015, the GAVI Alliance plans to help about 60 countries introduce this vaccine into their routine immunisation systems, reaching a total of 90 million children.

By helping to protect children with vaccines, GAVI partners and donors are supporting a major contribution to the Millennium Development Goal 4 which calls for a two thirds reduction in child mortality by 2015.

Key to this contribution has been GAVI’s Advance Market Commitment (AMC), an innovative finance mechanism that has accelerated the production of pneumococcal vaccines.

By concluding long-term supply agreements at a ceiling price, the AMC reduced market uncertainty, thereby encouraging manufacturers to develop adequate production capacity and supply at lower prices.

The AMC was made possible with US$ 1.5 billion from Italy, the United Kingdom, Canada, Russia, Norway, and the Bill & Melinda Gates Foundation, and is part of a broader GAVI plan to ensure that all children have equal access to life saving vaccines.

No child should die of a disease we can prevent.

Leave a comment:

IMPORTANT: Your comment will not appear immediately as we vet all messages before publication. We don't publish comments that are racist or otherwise offensive. Nor do we publish comments that advertise products or services. Please keep your comment concise and do not write in capitals.

Related Posts

  1. Immunisation a challenge in Mozambique, but future looks bright

    Posted: Wed., March 21, 5:28 PM | Comments (0)

    (Aid Worker Diaries)
  2. Will Twitter put the U.N. out of the disaster business?

    Posted: Sat., March 24, 9:37 PM | Comments (0)

    (TechnoTalk)

Recent Posts

  1. UNDP, Global Fund gain ground on malaria in Liberia and Tajikistan

    Posted: Thu., April 26, 4:02 PM | Comments (0)

    (Health and Science)
  2. The business of ending malaria

    Posted: Wed., April 25, 12:31 AM | Comments (0)

    (Health and Science)
  3. Combating a massive surge in malaria in eastern DRC

    Posted: Tue., April 24, 6:07 PM | Comments (0)

    (Health and Science)